ArticleJournal of managed care & specialty pharmacy2020

The Economic Burden of End-Organ Damage Among Medicaid Patients with Sickle Cell Disease in the United States: A Population-Based Longitudinal Claims Study.

Andrew Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.